Lymphoma Talk: Houston

Lymphoma Talk is a two-hour weekday evening in-person program led by lymphoma experts that provides information about lymphoma in three breakout sessions.

Date: Thursday, November 5, 2026

Time: 6:00 – 8:30 PM CT

Location: The Westin Houston Medical Center/Museum District
1709 Dryden Road
Houston, TX 77039

* Please note this is an in-person program. Please see the Lymphoma Research Foundation’s Health and Safety Protocol for more information.

You may also register by calling or emailing our Lymphoma Resource Center at 800-500-9976 or [email protected].

Program Agenda

6:00-6:15 PM CT Attendee Check-In

6:15 – 7:15 PM Buffet Dinner and Keynote Presentation

Keynote Presentation: Novel Therapies in Lymphoma and CLL – Paolo Strati, MD, UT MD Anderson Cancer Center

7:15-8:30 PM Educational Sessions (Select One)

Aggressive lymphomas (including diffuse large B-cell lymphoma, mantle cell lymphoma, Hodgkin lymphoma, and other aggressive lymphomas) – Dai Chihara, MD, PhD, UT MD Anderson Cancer Center
Indolent lymphomas (including follicular lymphoma, marginal zone lymphomas, Waldenstrom Macroglobulinemia, and other slow-growing lymphomas) – Speaker TBA
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) – Nijin Jain, MD, UT MD Anderson Cancer Center

8:30 PM CT Lymphoma Talk Concludes

Featured Speakers – TBA

This program is for patients and survivors, care partners and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email [email protected] to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation (the “Foundation”) is a national nonprofit organization based in the United States (U.S.) with educational programs and resources which are intended for a U.S. based audience. These programs and resources are intended for general educational and informational purposes only and do not constitute medical advice, diagnosis, or treatment, nor do they create a patient-provider relationship. Individuals who use Foundation programs and services should not rely on this information and are advised to consult a medical professional for medical advice, diagnoses, or treatment. The Foundation’s programs and resources address available lymphoma/CLL treatments in the U.S. and information on drug approvals by the U.S. Food and Drug Administration (FDA).

The Foundation does not endorse any treatments, products, or services mentioned in its resources. The information provided is for informational purposes only and should not be considered as an endorsement. The Foundation shall not be liable for any direct, indirect, incidental, special, consequential, or punitive damages arising out of the use of its programs and resources, to the extent permitted by law. You acknowledge and agree that any actions you take based on the information provided are taken at your own discretion and risk.

For individuals outside of the U.S. seeking information, the Foundation recommends the Lymphoma Coalition. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non-U.S.-based audiences. Additional information can be found by visiting their website at https://lymphomacoalition.org.

All content provided by the Foundation is protected by intellectual property laws. You may not reproduce, distribute, or otherwise use the content without the Foundation’s prior written consent.